Regeneron Pharmaceuticals (REGN)
Net Debt
-$469.20M
Quarterly · Period ending: · USD
REGN Net Debt
Latest reported-$469.20Mperiod ending
Latest reported-$469.20Mperiod ending
REGN Quarterly Net Debt (-$21.80M → -$469.20M)
Quarterly net debt
High-resolution chart · PNG
REGN net debt history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Net Debt (USD) |
|---|---|
| -140,638,000 | |
| -181,169,000 | |
| -28,297,000 | |
| -46,639,000 | |
| -78,309,000 | |
| -8,422,000 | |
| -19,600,000 | |
| -20,200,000 | |
| -16,900,000 | |
| -17,900,000 | |
| -15,600,000 | |
| -18,100,000 | |
| -17,700,000 | |
| -14,500,000 | |
| -23,300,000 | |
| -33,500,000 | |
| -44,100,000 | |
| -20,100,000 | |
| -25,800,000 | |
| -28,500,000 | |
| -40,300,000 | |
| -3,200,000 | |
| -23,200,000 | |
| 4,400,000 | |
| -5,800,000 | |
| -4,000,000 | |
| -11,300,000 | |
| -5,000,000 | |
| -8,600,000 | |
| 3,900,000 | |
| -5,000,000 | |
| -32,000,000 | |
| -100,000 | |
| -2,400,000 | |
| -9,600,000 | |
| -13,000,000 | |
| -16,300,000 | |
| -20,100,000 | |
| -23,400,000 | |
| -34,200,000 | |
| -38,800,000 | |
| -21,800,000 |